News Agency
Men's Weekly

Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand

  • Written by Media Outreach

Mounjaro® (tirzepatide) will be available in the market from the end of May 2025

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be...

Read more: Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand

How Signage Shapes Business Visibility And Customer Perception

In today’s competitive commercial environment, signage is far more than just a display element—it acts as a silent communicator between a business and its audience. Whether positioned outdoors or within a retail or corporate space, it provides immediate information about what... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion